It was also found in leukemia cells that non-coding variants at KRAS and PER2 enhancers affect the binding of nuclear receptor family TFs PPARG and RXRA, which disturbs the expression of KRAS and PER2 and promotes the growth of leukemia cells [14]. The gene discussed is KRAS; the disease is leukemia.